Guangdong Zhongsheng Pharmaceutical Co Ltd Net Asset Quality Index
Guangdong Zhongsheng Pharmaceutical Co Ltd net asset quality index. Guangdong Zhongsheng Pharmaceutical Co Ltd (002317) has a Net Asset Quality Index of 79.8% as of September 2025. This metric measures the proportion of total assets financed by shareholders' equity — total assets of CN¥5.17 Billion minus total liabilities of CN¥1.04 Billion yields net assets of CN¥4.13 Billion. A higher index indicates a stronger, lower-leverage balance sheet. See Guangdong Zhongsheng Pharmaceutical Co L (002317) shareholders funds for net asset value and shareholders' equity analysis.
Quality Index
Net Assets
Total Assets
Total Liabilities
Net Asset Quality Index of Guangdong Zhongsheng Pharmaceutical Co Ltd (2006–2024)
Net asset quality index of Guangdong Zhongsheng Pharmaceutical Co Ltd from 2006 to 2024. This chart shows how Guangdong Zhongsheng Pharmaceutical Co Ltd's Net Asset Quality Index has evolved across 19 annual periods from 2006 to 2024. As of September 2025, the index stands at 79.8%, representing net assets of CN¥4.13 Billion against total assets of CN¥5.17 Billion CNY. Check 002317 strategic assets to equity ratio to assess the company's strategic physical and investment asset allocation.
Guangdong Zhongsheng Pharmaceutical Co Ltd Net Asset Quality Index by Year (2006–2024)
Guangdong Zhongsheng Pharmaceutical Co Ltd net asset quality index by year from 2006 to 2024. The table below presents the year-by-year Net Asset Quality Index for Guangdong Zhongsheng Pharmaceutical Co Ltd from 2006 to 2024, covering 19 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see 002317 market cap.
| Year | Quality Index | Net Assets (CNY) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2024 | 72.2% | CN¥4.01 Billion | CN¥5.55 Billion | CN¥1.54 Billion | ▲ +2.1 pp |
| 2023 | 70.1% | CN¥4.53 Billion | CN¥6.46 Billion | CN¥1.93 Billion | ▲ +4.0 pp |
| 2022 | 66.1% | CN¥3.82 Billion | CN¥5.78 Billion | CN¥1.96 Billion | ▼ -6.1 pp |
| 2021 | 72.2% | CN¥3.54 Billion | CN¥4.90 Billion | CN¥1.36 Billion | ▼ -3.8 pp |
| 2020 | 75.9% | CN¥3.63 Billion | CN¥4.78 Billion | CN¥1.15 Billion | ▲ +0.8 pp |
| 2019 | 75.1% | CN¥4.13 Billion | CN¥5.51 Billion | CN¥1.37 Billion | ▼ -0.3 pp |
| 2018 | 75.3% | CN¥3.95 Billion | CN¥5.24 Billion | CN¥1.29 Billion | ▼ -1.5 pp |
| 2017 | 76.8% | CN¥3.73 Billion | CN¥4.86 Billion | CN¥1.13 Billion | ▼ -4.2 pp |
| 2016 | 81.0% | CN¥3.42 Billion | CN¥4.23 Billion | CN¥801.23 Million | ▲ +17.8 pp |
| 2015 | 63.3% | CN¥2.11 Billion | CN¥3.33 Billion | CN¥1.22 Billion | ▼ -19.1 pp |
| 2014 | 82.3% | CN¥1.90 Billion | CN¥2.31 Billion | CN¥407.63 Million | ▼ -5.7 pp |
| 2013 | 88.0% | CN¥1.74 Billion | CN¥1.98 Billion | CN¥238.04 Million | ▼ -3.4 pp |
| 2012 | 91.3% | CN¥1.59 Billion | CN¥1.74 Billion | CN¥150.41 Million | ▼ -2.8 pp |
| 2011 | 94.1% | CN¥1.48 Billion | CN¥1.57 Billion | CN¥92.54 Million | ▲ +0.6 pp |
| 2010 | 93.6% | CN¥1.39 Billion | CN¥1.48 Billion | CN¥95.53 Million | ▲ +1.3 pp |
| 2009 | 92.3% | CN¥1.30 Billion | CN¥1.40 Billion | CN¥108.46 Million | ▲ +37.5 pp |
| 2008 | 54.7% | CN¥172.40 Million | CN¥314.92 Million | CN¥142.53 Million | ▲ +10.9 pp |
| 2007 | 43.9% | CN¥130.56 Million | CN¥297.74 Million | CN¥167.17 Million | ▼ -3.7 pp |
| 2006 | 47.6% | CN¥138.72 Million | CN¥291.65 Million | CN¥152.93 Million | — |